This and related knowledge, together with the understanding that global human RAMP1 transgenic mice are protected from hypertension,17 led us to hypothesize that a stabilized α-CGRP agonist with the ability to remain active over prolonged periods would elicit cardioprotective properties. This evidence concerns the gene RAMP1 and hypertensive disorder.